期刊文献+

乳腺癌组织中EGF和ALDH1A1的表达及其临床意义 被引量:3

Expression and significance of EGF and ALDH1A1 in breast cancer
下载PDF
导出
摘要 目的研究表皮生长因子(EGF)与乙醛脱氢酶(ALDH1A1)在正常乳腺组织及乳腺癌组织中的表达及意义,探讨EGF在乳腺癌干细胞演进过程中的作用。方法采用RT-PCR和免疫组化方法分别检测24例正常乳腺组织和45例乳腺浸润性导管癌组织中EGF和ALDH1A1的表达情况。结果 RT-PCR结果显示,乳腺癌中EGF与ALDH1A1的mRNA水平高表达,在正常乳腺组织中低表达或不表达,两组比较P<0.01。免疫组化结果显示,EGF在正常乳腺与乳腺癌中的表达分别为20.8%和75.6%,ALDH1A1在正常乳腺与乳腺癌中的表达分别为16.7%与66.4%,乳腺癌中EGF与ALDH1A1蛋白水平表达明显高于正常组织(P<0.01)。EGF与ALDH1A1两者在乳腺癌中表达存在正相关(P<0.05)。EGF的表达与发病年龄、肿瘤大小、组织学分型、有无淋巴结转移、PR表达无相关性,与ER表达呈正相关(P<0.01);ALDH1A1的表达与发病年龄、肿瘤大小、有无淋巴结转移、ER、PR表达无相关性,与组织学分型呈正相关(P<0.05)。结论 EGF与ALDH1A1在乳腺癌组织中的表达高于正常乳腺组织,EGF与乳腺癌干细胞的发生发展关系密切。 Objective To examine the expression and significance of EGF and ALDHl Al in the benign and malignant lesions of human mammary gland, and to investigate the role of EGF on breast cancer stem cell progression. Method RT PCR and immunohistochemistry methods were used to detect the expression levels of EGF and ALDHlAl in the following two groups: 24 normal breast tissues and 45 breast cancer tissues. Results RT-PCR results showed that mRNA levels of EGF and ALDHl Al were higher in breast cancer than those in normal tissues (P〈0.01 ). The positive rate of EGF protein in normal breast tissues and breast cancer tissues was 20.8% and 75.6% , and the positive rate of ALDH1A1 protein was 16.7% and 66.4% respectively. The positive rates of EGF and ALDH1A1 expression in breast cancer and normal tissues had a significant difference (P 〈0.01 ). In breast cancer, the expression of EGF protein was positively correlated to that of ALDH1 A1 protein (P 〈 0.05 ). The expression of EGF protein was significantly associated with the expression of ER (P 〈 0.01 ), but was not significantly correlated to the age of onset, tumor size, pathological grade, lymphatic metastasis and PR. The expression of ALDHl Al protein was significantly associated with the expression of pathological grade ( P 〈0.05 ), but was not significantly correlated to the age of onset, tumor size, lymphatic metastasis, ER and PR. Conclusions The expression of EGF and ALDH1A1 are lower in normal breast tissues than in breast cancer tissues. EGF may play an impor tant role in the pathogenesis and development of breast cancer stem cell.
出处 《山东医药》 CAS 2012年第32期1-3,7,I0001,共5页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30870968) 教育部高等学校博士学科点专项科研基金(200801610001)
关键词 乳腺肿瘤 表皮生长因子 肿瘤干细胞 breast neoplasms epidermal growth factor tumor stem cell
  • 相关文献

参考文献15

  • 1AI-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective i- dentification of tumourigenie breast cancer ceils [ J ]. Proc Natl Acad Sci U S A, 2003,100(7) :3983-3988.
  • 2Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a mark- er of normal and malignant human mammary stem cell and a predic- tor of poor clinical outcome [ J ]. Cell Stem Cell, 2007,1 (5) :485- 487.
  • 3Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of alde- hyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells [ J ]. Proc Natl Acad Sci U S A, 2006,103 (31) :11707-11712.
  • 4Gundersen H J, Bagger P, Bendtse FT. The new sterological tools: disector, fractionators and point samples intercept and their use in pathological research and diagnosis [ J ]. APMIS, 1988,96 ( 10 ) : 857-860.
  • 5廖小金.表皮生长因子结构和生物学效应[J].海峡药学,2006,18(5):14-17. 被引量:21
  • 6Pearce D J, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and a- cute myeloid leukemia samples [ J ]. Stem Cell, 2005,23 ( 6 ) : 752-760.
  • 7Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long term reconstituting human hemat opoietic stem cells [ J ]. Blood, 2006,107 (5) :2162- 2169.
  • 8Lugli A, Izi G, Hostettler I, et al. Prognostic impact of the ex- pression of putative cancer stem cell markers CD133 , CDI66 , CD,14s, EpCAM, and ALDH1 in colorectal cancer [J]. Br J Cancer, 2010, 103 (3) :382-390.
  • 9Jiang F, Qiu Q, Khanaa A, et al. Aldehyde dehydrogenasel is atumor stem cell associated marker in lung cancer [ J ]. Mol Cancer Res, 2009,7 (3) :330-338.
  • 10Seigel GM, Campbell LM, Narayan M, et al. Cancer stem cell char- acteristics in retinoblastoma [ J ]. Mol Vis, 2005,11:729-737.

二级参考文献26

  • 1Huangbing-Ren.A brief introduction of the EGF application[J].Basic Clin Med,1991,11:7~9.
  • 2Savage C R,Hash J H,Cohen S.Epidermal growth factor:location of disulfide bonds[J].J Biol Chen,1973,247:7612~7622.
  • 3Wilson SE,Llody SA.Epidermal growth factor and its receptor,basic fibroblast growth factor,transforming growth factor beta-1 and interleukin-1 alpha messenger RNA production in human corneal indothelial cells[J].Invest Ophthalmol Vis Sci,1991,32:2747~2752.
  • 4Taylor J M,Michel W M,Cohen S.Epidermal growth factor:physical and chemical propeties[J].J Biol Chem,1972,247:5928~5934.
  • 5Cohen S,Savage CR Jr.Recent studies on the chemistry and biology of epithelial gromth factor.Recent Prog Horm Res,1974,30(2):551~556.
  • 6Grazybowshi J,Clolak E,Janiak M.Klocal application of G-CSF,CM-CSFand EGF in treatment of wounds[J].Postepy Hig Med Dosw,1999,53(1):75~86.
  • 7Gibbs S,Silva Pinta AN,Murlis,etal.Epidermal growth factor and kerorinocyte growth factor differentially regulate epidermal migration growth and differentation[J].Wound Repair Regen,2000,8(3):192.
  • 8Raper SE,Burwen SJ,Barker ME,et al.Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration[J].Gastroenterology,1987,92:1243.
  • 9Suslov ON,Kukelov VG,Ignatova TN,et al.Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres[J].Pro Natl Acad Sci USA,2002,99(22):14506.
  • 10Galvink A,Jones DG.Adult human neural stem cells for cell replacement therapies in the central nervous stem[J].Med J Aust,2002,177(6):316.

共引文献49

同被引文献30

  • 1于德新,高志芹.肿瘤血管生长抑制因子与肝细胞癌关系研究进展[J].肿瘤防治杂志,2005,12(17):1350-1354. 被引量:1
  • 2TORRE L A,BRAY F,SIEGEL R L,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
  • 3YU Y,RAMENA G,ELBLE R C.The role of cancer stem cells in relapse of solid tumors[J].Front Biosci(Elite Ed),2012,4(4):1528-1541.
  • 4REYA T,MORRISON S J.CLARKE M F.et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414(6859):105-111.
  • 5MA I,ALLAN A L.The role of human aldehyde dehydrogenase in normal and cancer stem cells[J].Stem Cell Rev,2011,7(2):292-306.
  • 6ZHENG R,WANG J,WU Q,et al.Expression of ALDHl and TGFβ2in benign and malignant breast tumors and their prognostic implications[J].Int J Clin Exp Pathol,2014,7(7):4173-4183.
  • 7GINESTIER C,HUR M H,CHARAFE-JAUFFRET E,et al.ALDH1is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J].Cell Stem Cell,2007,1(5):555-567.
  • 8JIANG F,QIU Q.KHANNA A,et al.Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer[J].Mol Cancer Res,2009,7(3):330-338.
  • 9CHANG B.LIU G,XUE F,et aJ.ALDH1 expression correlates with favorable prognosis in ovarian cancers[J].Mod Pathol,2009,22(6):817-823.
  • 10HUANG E H,HYNES M J,ZHANG T,et al.Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells(SC)and tracks SC overpopulation during colon tumorigenesis[J].Cancer Res,2009,69(8):3382-3389.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部